Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$2.99 - $4.9 $1.38 Million - $2.25 Million
-460,000 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$1.83 - $3.45 $10.9 Million - $20.5 Million
-5,956,000 Reduced 92.83%
460,000 $1.07 Million
Q4 2019

Feb 14, 2020

SELL
$3.5 - $10.35 $16 Million - $47.2 Million
-4,559,800 Reduced 41.54%
6,416,000 $23.4 Million
Q3 2019

Nov 13, 2019

SELL
$7.03 - $9.7 $1.06 Million - $1.46 Million
-150,200 Reduced 1.35%
10,975,800 $91 Million
Q2 2019

Aug 14, 2019

BUY
$7.36 - $11.26 $493,120 - $754,420
67,000 Added 0.61%
11,126,000 $95.8 Million
Q1 2019

May 14, 2019

BUY
$9.08 - $11.84 $229,451 - $299,196
25,270 Added 0.23%
11,059,000 $118 Million
Q4 2018

Feb 12, 2019

SELL
$6.39 - $16.99 $806,865 - $2.15 Million
-126,270 Reduced 1.13%
11,033,730 $96.5 Million
Q3 2018

Nov 13, 2018

BUY
$16.52 - $24.82 $17.1 Million - $25.7 Million
1,034,000 Added 10.21%
11,160,000 $187 Million
Q2 2018

Aug 13, 2018

BUY
$14.31 - $21.75 $38.7 Million - $58.9 Million
2,706,000 Added 36.47%
10,126,000 $212 Million
Q1 2018

May 14, 2018

BUY
$16.09 - $23.07 $45.9 Million - $65.8 Million
2,854,000 Added 62.51%
7,420,000 $119 Million
Q4 2017

Feb 13, 2018

BUY
$13.36 - $20.73 $7.48 Million - $11.6 Million
560,000 Added 13.98%
4,566,000 $86.5 Million
Q3 2017

Nov 13, 2017

BUY
$8.75 - $14.07 $35.1 Million - $56.4 Million
4,006,000
4,006,000 $56.4 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.